Home/Filings/4/0001610618-21-000089
4//SEC Filing

Tari Leslie 4

Accession 0001610618-21-000089

CIK 0001610618other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 9:23 PM ET

Size

5.5 KB

Accession

0001610618-21-000089

Insider Transaction Report

Form 4
Period: 2021-09-30
Tari Leslie
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Common Stock

    2021-09-30+148,000150,551 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    13,298
Footnotes (1)
  • [F1]All RSUs vest in three equal annual installments, with 1/3 vesting on each of September 10, 2022, 2023, and 2024, subject to continuous service through each such vesting date.

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1
  • filerCIK 0001870270

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 9:23 PM ET
Size
5.5 KB